Login Register
About Us
Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Advanced Search
Back
4Engineers

Thermo Fisher Scientific to sell its microbiology business as Astorg

This article was originally posted on Chemical Engineering Online.
View article ->
Summary
Thermo Fisher Scientific will sell its microbiology business—provider of antimicrobial susceptibility testing (AST) and clinical culture media solutions—to pan-European private equity firm Astorg for approximately $1.075 billion, comprising cash and a $50 million seller note.

What impact do you think this divestiture will have on innovation, pricing, and service levels in the clinical AST and culture media market?

Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, […]

The post Thermo Fisher Scientific to sell its microbiology business as Astorg appeared first on Chemical Engineering.

Login to comment

Login

Related Conversations

Recent Conversations

Your Conversations

Report content
Reason Description